Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mana Mitsuguro"'
Autor:
Mana Mitsuguro, Reiko Neki, Kazufumi Ida, Chizuko Kamiya, Naoko Iwanaga, Akira Okamoto, Jun Yoshimatsu, Toshiyuki Miyata, Takekazu Miyoshi
Publikováno v:
International journal of hematology. 110(5)
Heparin anticoagulant therapy for thromboembolic disorders during pregnancy is problematic due to unexpected adverse bleeding. To avoid bleeding, we have used a less-intensive anticoagulation protocol of unfractionated heparin (UFH). The protocol had
Autor:
Tatsuya Araki, Shigeki Miyata, Yoshie Shironouchi, Takayoshi Hamamoto, Jun Yoshimatsu, Reiko Neki, Akira Okamoto, Toshiyuki Miyata, Mana Mitsuguro, Michitaka Sano
Publikováno v:
International Journal of Hematology. 101:119-125
In pregnant women, activated partial thromboplastin time (APTT) does not precisely reflect the anticoagulant effect of a therapeutic dose of heparin. However, the measurement of anti-Xa activity can be used to monitor the anticoagulant effect of hepa
Autor:
Akira Okamoto, Toshiyuki Miyata, Mana Mitsuguro, Michitaka Sano, Yoshihiro Kokubo, Toshiyuki Sakata, Sachika Kameda
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 18:560-567
Aim: Platelets play a pivotal role in atherothrombotic diseases. Platelet aggregability induced by agonists has great interindividual variability; however, the factors influencing platelet aggregability variation have not been characterized in Asia.M
Autor:
Yoshihiro Kokubo, Mana Mitsuguro, Toshiyuki Sakata, Michitaka Sano, Sachika Kameda, Yoshiaki Tsutsumi, Akira Okamoto, Toshiyuki Miyata
Publikováno v:
International journal of hematology. 92(3)
Inherited antithrombin deficiency, an established risk factor for venous thromboembolism (VTE), can be classified into type I (quantitative deficiency) or type II (qualitative deficiency). In the present study, we assessed the VTE risk associated wit